OpenAlex
PricingAboutJobs
Log inGet started
Work

Recombinant DNA Technology in the Treatment of Diabetes: Insulin Analogs

HTML

Year: 2001
Type: review
Source: Endocrine Reviews
DOI: 10.1210/edrv.22.5.0442
Authors: Zoltan Vajo, Janet Fawcett, William C. Duckworth
Institutions: Phoenix VA Health Care System, Carl T. Hayden Veterans Affairs Medical Center
Language: English

Topic: Diabetes Management and Research
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: insulin analogues, recombinant DNA technology, diabetes treatment, human insulin, insulin lispro, insulin glargine, insulin aspart, rapid-acting insulin, long-acting insulin, glycemic control, hypoglycemia
SDG: Good health and well-being

Open Access status: closed

Funder: Novo Nordisk
OpenAlex ID: W2169013246
FWCI: 0.883
Cites: 114
Cited by: 191
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms